Cargando…
Metformin and blood cancers
Type 2 diabetes mellitus and cancer are correlated with changes in insulin signaling, a pathway that is frequently upregulated in neoplastic tissue but impaired in tissues that are classically targeted by insulin in type 2 diabetes mellitus. Many antidiabetes treatments, particularly metformin, enha...
Autores principales: | Cunha Júnior, Ademar Dantas, Pericole, Fernando Vieira, Carvalheira, Jose Barreto Campello |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6113924/ https://www.ncbi.nlm.nih.gov/pubmed/30208162 http://dx.doi.org/10.6061/clinics/2018/e412s |
Ejemplares similares
-
Obesity as a Possible Risk Factor for Progression from Monoclonal Gammopathy of Undetermined Significance Progression into Multiple Myeloma: Could Myeloma Be Prevented with Metformin Treatment?
por: da Cunha Júnior, Ademar Dantas, et al.
Publicado: (2021) -
Repurposing metformin for the treatment of gastrointestinal cancer
por: Cunha Júnior, Ademar Dantas, et al.
Publicado: (2021) -
Myosteatosis Differentially Affects the Prognosis of Non-Metastatic Colon and Rectal Cancer Patients: An Exploratory Study
por: Pozzuto, Lara, et al.
Publicado: (2021) -
Metformin plus lrinotecan in patients with refractory colorectal cancer: a phase 2 clinical trial
por: Bragagnoli, Arinilda Campos, et al.
Publicado: (2021) -
Outcomes of COVID-19 Patients under Cytotoxic Cancer Chemotherapy in Brazil
por: Duarte, Mateus Bringel Oliveira, et al.
Publicado: (2020)